72
|
298
|
7kacA |
Crystal structure of hpk1 (map4k1) kinase in complex with 5-{[4-{[(1s)-2-hydroxy-1-phenylethyl]amino}-5-(1,3,4-oxadiazol-2-yl)pyrimidin-2-yl]amino}-3,3-dimethyl-2-benzofuran-1(3h)-one |
113
|
328
|
7avqA |
Crystal structure of haspin in complex with disubstituted imidazo[1,2- b]pyridazine inhibitor (compound 12) |
115
|
334
|
7a49A |
Crystal structure of human protein kinase ck2alpha (csnk2a1 gene product) in complex with the atp-competitive inhibitor 6-bromo-5-chloro-1h-triazolo[4,5-b]pyridine |
78
|
268
|
7ayiA |
Crystal structure of aurora a in complex with 7-(2-anilinopyrimidin-4-yl)-1-benzazepin-2-one derivative (compound 2a) |
85
|
281
|
7b32A |
Mst3 in complex with mria7 |
113
|
327
|
7a1bA |
Crystal structure of human protein kinase ck2alpha' (csnk2a2 gene product) in complex with the atp-competitive inhibitor 5,6-dibromo-1h-triazolo[4,5-b]pyridine |
24
|
134
|
6xguB |
Crystal structure of kras-q61r (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf |
282
|
939
|
7k6mA |
Crystal structure of pi3kalpha selective inhibitor pf-06843195 |
115
|
325
|
7a2hA |
Crystal structure of human protein kinase ck2alpha' (csnk2a2 gene product) in complex with the atp-competitive inhibitor 5,6,7-tribromo-1h-imidazo[4,5-b]pyridine |
112
|
333
|
7a4bA |
Crystal structure of human protein kinase ck2alpha (csnk2a1 gene product) in complex with the atp-competitive inhibitor 5,6-dibromo-1h-triazolo[4,5-b]pyridine |
93
|
295
|
6thxA |
Irak4 in complex with inhibitor |
122
|
333
|
6tluAAA |
Human ck2 kinase alpha subunit in complex with the atp-competitive inhibitor 4,5-dibromobenzotriazole |
129
|
333
|
6tlsA |
Human ck2 kinase alpha subunit in complex with the atp-competitive inhibitor 4,6-dibromobenzotriazole |
83
|
273
|
6vruA |
Pim-inhibitor complex 1 |
94
|
401
|
6w3eA |
Structure of phosphorylated ire1 in complex with g-0701 |
127
|
402
|
6w3kA |
Structure of unphosphorylated human ire1 bound to g-9807 |
0
|
10
|
6wjqC |
Crystal structure of wdr5 in complex with the win peptide of pdpk1 |
75
|
273
|
6v31A |
Crystal structure of the braf:mek1 kinases in complex with amppnp and ch5126766 |
128
|
402
|
6w3bA |
Structure of apo unphosphorylated ire1 |
75
|
275
|
6v2wA |
Crystal structure of the braf:mek1 kinases in complex with amppnp |
82
|
271
|
6vrvA |
Discovery of sarxxxx92, a pan-pim kinase inhibitor, efficacious in a kg1 tumor model |
96
|
403
|
6w3aA |
Structure of unphosphorylated ire1 in complex with g-7658 |
89
|
295
|
6ti8A |
Irak4 in complex with inhibitor |
125
|
405
|
6w3cA |
Structure of phosphorylated apo ire1 |
79
|
274
|
6v2zA |
Crystal structure of the braf:mek1 kinases in complex with amppnp and cobimetinib |
122
|
401
|
6w39A |
Structure of unphosphorylated ire1 in complex with g-1749 |
75
|
274
|
6v32A |
Crystal structure of the braf:mek1 kinases in complex with amppnp and selumetinib |
17
|
77
|
6vjjB |
Crystal structure of wild-type kras4b (gmppnp-bound) in complex with ras-binding domain (rbd) of raf1/craf |
24
|
130
|
6xi7B |
Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form i) |
23
|
134
|
6xgvB |
Crystal structure of kras-g13d (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf |
86
|
297
|
6tiaA |
Irak4 in complex with inhibitor |
71
|
273
|
6v2uA |
Crystal structure of the insect cell-expressed wt-braf kinase in complex with dabrafenib |
75
|
274
|
6v30A |
Crystal structure of the braf:mek1 kinases in complex with amppnp and pimasertib |
128
|
333
|
6tlvA |
Human ck2 kinase alpha subunit in complex with the atp-competitive inhibitor 5-bromobenzotriazole |
77
|
275
|
6v2yA |
Crystal structure of the braf:mek1 kinases in complex with amppnp and trametinib |
126
|
333
|
6tloA |
Human ck2 kinase alpha subunit in complex with the atp-competitive inhibitor 4,5,6-tribromobenzotriazole |
23
|
134
|
6xhbB |
Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form ii) |
124
|
333
|
6tlwA |
Human ck2 kinase alpha subunit in complex with the atp-competitive inhibitor 4-bromobenzotriazole |
73
|
274
|
6v2xA |
Crystal structure of the braf:mek1 kinases in complex with amppnp and binimetinib |
86
|
294
|
6thzA |
Irak4 in complex with inhibitor |
77
|
276
|
6v2vA |
Crystal structure of the braf:mek1 kinases in complex with amppnp and pd0325901 |
93
|
295
|
6thwA |
Irak4 in complex with inhibitor |
123
|
333
|
6tlrA |
Human ck2 kinase alpha subunit in complex with the atp-competitive inhibitor 4,7-dibromobenzotriazole |
122
|
333
|
6tlpA |
Human ck2 kinase alpha subunit in complex with the atp-competitive inhibitor 5,6-dibromobenzotriazole |
123
|
333
|
6tllA |
Human ck2 kinase alpha subunit in complex with the atp-competitive inhibitor 4,5,6,7-tetrabromobenzotriazole (tbbt) |
83
|
284
|
6seqA |
Lemur tyrosine kinase 3 (lmtk3) |
20
|
134
|
6xhaB |
Crystal structure of kras-g12v (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf |
101
|
253
|
7jjhA |
Crystal structure of the unliganded tandem bromodomain (bd1, bd2) of human taf1 |
91
|
276
|
7ccwA |
Crystal structure of death-associated protein kinase 1 in complex with resveratrol and mes |
85
|
276
|
7ccvA |
Crystal structure of death-associated protein kinase 1 in complex with piceatannol |